Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
French (FR)
2021
Europe
Clear all
Type of publications
NITAG documentation
(29)
Topics
Regions
Europe
(29)
Africa
(3)
Americas
(4)
Countries
Belgium
(13)
France
(16)
Diseases
COVID-19
(29)
Influenza
(2)
Pneumococcal disease
(1)
Publication date
2021
(29)
2023
(2)
2022
(10)
2020
(4)
Target population
Adults
(1)
Pregnant women
(1)
Risk group
(1)
Available to download in languages
French (FR)
(29)
English (EN)
(36)
German (DE)
(7)
Spanish (ES)
(1)
Swedish (SV)
(1)
29 results found
2021
∙
Conseil Supérieur de la Santé (CSS)
Belgian recommendation of an additional dose of COVID-19 mRNA vaccine (Part one)
2021
Booster dose for healthcare workers
2021
∙
Conseil Supérieur de la Santé (CSS)
Co-administration of COVID-19 vaccines with other vaccines (simultaneous vaccination)
2021
∙
Conseil Supérieur de la Santé (CSS)
CSS Recommendations for vaccination against SARS-CoV-2 in pregnant women, women wishing to become pregnant or breastfeeding using a messenger RNA vaccine - 15 April, 2021
2021
∙
Haute Autorité de Santé
HAS opinion relating to the launch of the 2021/2022 vaccination campaign against seasonal influenza in France in the northern hemisphere and in Mayotte in the context of the 'Covid-19 epidemic - May 12, 2021.
2021
∙
Haute Autorité de Santé
HAS recommendation on Place of Moderna's Spikevax® mRNA vaccine in 12 to 17 year olds - July 28, 2021
2021
∙
Haute Autorité de Santé
HAS recommendation on the place of a booster with the COMIRNATY mRNA vaccine
2021
∙
Haute Autorité de Santé
HAS recommendation on Vaccination strategy against Covid-19 - Place of the COMIRNATY® mRNA vaccine in 12-15 year olds - 3 June, 2021
2021
∙
Haute Autorité de Santé
HAS Sars-Cov-2 vaccination strategy - Role of socio-economic and professional factors in the risk of infection and severe forms of Covid-19 and updating of recommendations - 1 July 2021
2021
∙
Haut Conseil de la santé publique
HAS statement on AstraZeneca vaccine in response to new vaccine safety concerns - 8 April, 2021
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register